Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Clinical Trial Results
Pharma
Merck releases results from successful trial of Winrevair
Merck's phase 3 Hyperion study showed that Winrevair reduced the risk of clinical worsening events by 76% in recently diagnosed adults with PAH.
Kevin Dunleavy
Sep 30, 2025 8:00am
Fierce Biotech
Biohaven trashes troriluzole in OCD after ph. 3 fail
Aug 12, 2025 2:06pm
Eli Lilly eyes tirzepatide cardio filings after late-stage win
Aug 1, 2024 10:01am
Gilead trumpets a Biktarvy win in HIV, hepatitis B co-infection
Aug 1, 2022 10:17am
The FDA says Ocugen needs to hand over results from a 2019 study
Apr 26, 2022 8:40am
AZ, Daiichi's Enhertu touts HER2-low breast cancer win
Feb 22, 2022 8:55am
Fierce Biotech
Fierce Biotech
Fierce Biotech
Fierce Biotech
